Full Length Research Paper
References
|
Agbre-Yace M, Oyenusi E, Oduwole A, Ake M, Abodo J (2016). Prevalence of diabetes mellitus among children and adolescents in the district of Abidjan in Cote d'Ivoire: a population-based study. Journal of Diabetes and Metabolic Disorders 15:1-9. |
|
|
Aguiyi J, Obi C, Gang S, Igweh A (2000). Hypoglycaemic activity of Ocimum gratissimum in rats. Fitoterapia 71(4):444-46. |
|
|
Arya S, Jogender S, Singh S (2013). Antidiabetic activities of Cassia occidentalis. Recent Research in Science and Technology 5(1):51-53. |
|
|
Collins A, Foley R, Gilbertson D et Chen S (2015). United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease. Kidney International Supplements 5(1):2-7. |
|
|
Effo K, Djadji A, N'Guessan B, Kouakou S, Anzoua E, Fatto N and Kouakou-Siransy N (2018). Evaluation anti-inflammatory activity and ulcerogenic Risk of "Sarenta", an Ivorian Herbal Preparation. Journal of Pharmaceutical Research Science and Technology 2(3):1-7. ISSN: 2581-3080 |
|
|
Fattoh N (2017). Analgesic, morphine, antioxidant, anti-inflammatory activity and quality of " Sarenta ": a traditional herbal remedy. Pharmacy thesis: Abidjan. Felix Houphouët University Boigny. Faculty of Pharmacy 166 p. |
|
|
Festing M (1979). Suitability rat for fifferent investigations. In: Inbred and genetically defined strains of laboratory animals, Part I, Mouse and Rat (PL Altman, DD Katz, Eds.). Federation American Society Experimental Biology. Bethesda, MD, pp. 237-238. |
|
|
Gribble F, Reimann F (2003). Sulphonylurea action revisited: post-cloning era. Diabetology 46(7):875-91. |
|
|
Grimaldi A (2009). Treatise on Diabetology, 2nd Edition. Medicine Sciences, Flammarion. |
|
|
Goetz P (2007). Phytotherapy of diabetes, Phytotherapy 5:212-17. |
|
|
Kambouche N, Merah B, Derdour A, Bellahouel S, Younos C, Soulimani R (2011). Antihyperglycemic activity of a β- sitoglucoside sterol isolated from Anabasis plant articulated (Forssk) Moq. Phytotherapy 9:2-6. |
|
|
Kouakou-Siransy G, Effo K, Irie-Nguessan G, Koua E (2017). Analgesic efficacy, quality and safety of "Sarenta": An Herbal Preparation from Ivorian Traditional Medicine. International Journal of Pharmacology 13(3):257-265. |
|
|
Louhimies S (2002). Directive 86/609/EEC on the protection of animals used for experimental and other scientific purposes. Alternate Laboratory Animals 30(2):217-219. |
|
|
Magnan C, Ktorza A (2005). Production and secretion of insulin by pancreatic β cell. EMC-Endocrinologie 2(4):241-264. |
|
|
Maiti R, Jana D, Das U, Ghosh D (2004). Antidiabetic effect of aqueous extract of seed of Tamarindus indica in streptozotocin-induced diabetic rats. Journal of Ethnopharmacology 92(1):85-91. |
|
|
Moxey PW, Gogalniceanu P, Hinchliffe RJ, Loftus IM, Jones KJ, Thompson MM, Holt PJ (2011). Lower extremity amputations- A review of global variability in incidence. Diabetic Medicine 28(10):1144-1153. |
|
|
N'guessan-Irié G, Tako A, Effo E, Kouakou L, Kouakou G (2019). Hyperglycaemia lowering activity and hypoglycaemic risk assessment of Sarenta, an Ivorian traditional herbal. International Journal of Basic and Clinical Pharmacology 141:8-9 |
|
|
Organisation for Economic Co-operation and Development (OECD) (2008). Test No. 407: repeated dose 28-day oral toxicity study in rodents. OECD Publishing. |
|
|
Rasolofoson M (2017). Study activity of codified extract No. 4 in mice hyperglycemia. Pharmacy thesis: Madagascar. Antananarivo University 21 p. |
|
|
Shin JW, Seol IC, Son CG (2010). Interpretation of animal dose and human equivalent dose for drug development. The Journal of Korean Medicine 31(3):1-7. |
|
|
Sherwood L, Berthet J, Amar-Costesec A (2013). Human physiology. 2nd edition ch. XVII. Paris (France): Ed. New Horizons, P. 562-572. |
|
|
Shrayyef M, Gerich J (2010). Normal glucose homeostasis. Principle of Diabetes pp. 19-35. |
|
|
Thulé P, Umpierrez G (2014). Sulfonylureas: a new look at old therapy. Current Diabetes Reports 14:1-8. |
|
|
Tremblay L, Faucher J, Bergeron A (2009). Taming your diabetes. Outpatient program of HCLM Diabetes Education Center, 3rd edition, Charles LeMoyne Hospital pp. 4-48. |
|
|
World Health Organization (WHO) (2016). Genève. Profils des pays pour le diabète. OMS. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
